Overview

Find essential information and guidelines on the board charter, meeting participation, and reporting requirements to enhance the effectiveness and transparency of board activities.

Members

Board members serve three-year terms, though some may be appointed to complete unexpired terms in the event of a vacancy or remain as holdovers until a successor is appointed. 

Agency leadership members serve continuously by virtue of their position (Commissioners of OASAS, OMH, DOH, and the Director of the Division of the Budget).

Chair and Vice Chair 

Debra Pantin, MSW, MS-HCM

Appointed By: Association of Counties 
Date of Appointment: February 18, 2026
 

Debbie Pantin currently serves as the Chair of the New York State Opioid Settlement Fund Advisory Board (OSFAB). She began her career as a social worker and advanced into executive leadership in healthcare management, with a focus on integrating and expanding mental health, substance use, and healthcare services. She also has considerable experience working in housing and shelter programs.
 

Debbie has served as CEO of prominent organizations such as VIP Community Services and Outreach Development Corporation, overseeing programs that serve thousands of individuals annually. She now provides consulting services across the behavioral health sector, supporting organizations in strategy, operations, and system transformation. She also serves as a member of both the New York State Behavioral Health Advisory Council and the Substance Use Subcommittee of the New York City Community Services Board.
 

Her leadership, expertise, and compassion continue to shape and advance the behavioral health field’s approaches to substance use and mental health care.

Dr. Justine Waldman, MD

Appointed By: Speaker of the Assembly
Date of Appointment: March 17, 2022
 

Dr. Justine Waldman (She/Her) serves as Vice-Chair of the New York State Opioid Settlement Fund Advisory Board (OSFAB). She is Board Certified in Addiction Medicine, Emergency Medicine, and a Fellow of the American College of Emergency Physicians. 

She is the CEO and CMO of Reach (Respectful, Equitable Access to Compassionate Health) Medical in Ithaca, NY which opened in 2018. REACH houses a fully integrated low threshold harm reduction medical and outreach practice for people who tend to face stigma in the current medical system. 

 

Members

Dr. Charles E. Argoff, MD

Appointed By: The Association of Counties
Date of Appointment: January 28, 2025

Charles E. Argoff, MD, is a Professor of Neurology at Albany Medical College, Vice-Chair of the Department of Neurology, and Director of the Comprehensive Pain Center at Albany Medical Center. He is also the Director of the Pain Management Fellowship in Albany, NY. Dr. Argoff is Immediate Past President of the American Academy of Pain Medicine. 

He is one of the editors of the recently published textbook Raj’s Practical Management of Pain, Sixth Edition, and co-author of Defeat Chronic Pain Now, a book written for people with chronic pain. He has recently published the fourth edition of Pain Management Secrets.  

Linda L. Beers, MPH

Appointed By: Minority Leader of the Assembly
Date of Appointment: May 15, 2025 
 

Linda L. Beers (she/her) serves as the Director of Public Health for the Essex County Health Department. In this role, she oversees the Public Health, Home Health, Children’s Services, and WIC units, advancing a broad range of programs that support the department’s vision of healthy people in healthy communities. 

Linda chairs the Essex County Heroin (ECHO) initiative and works closely with the CDC and HIDTA to refine and expand Opioid Fatality Review (OFR) efforts. She was recently featured in a national training on establishing OFRs, sharing her expertise with communities across the country. Her service includes roles on the Community Services Board, suicide prevention initiatives, the NYS Health Foundation, and the NYSAC Public Health and Mental Health Committee, and she is a past president of NYSACHO. She is also a member of the planning committee for the 2026 Harm Reduction Symposium. 
 

Drawing from lived experience supporting a family member through treatment, incarceration, and recovery, Linda is a tireless advocate for reducing stigma and promoting understanding of addiction as a chronic disease. A Poughkeepsie native now representing rural communities, she brings insight into both rural and urban perspectives and the unique intersections between them.

Lawrence S. Brown, Jr., MD, MPH, FACP, DFASAM

Appointed By: Temporary President of the Senate
Date of Appointment: February 7, 2022 (effective March 18, 2022)

Lawrence S. Brown is the former CEO of an addiction treatment program (now called START Cares). Dr. Brown has expertise in clinical care and clinical and behavior research in addiction medicine and public health. He also has experience in health services, restorative justice, and advocacy for youth services. 

Dr. Brown attended Brooklyn College (Bachelor of Arts), New York University (Doctor of Medicine), Columbia University (Master of Public Health), Harlem Hospital (Internal Medicine), and Columbia University (Fellow in Endocrinology). He is a Diplomate of the American Board of Addiction Medicine, Fellow of the American College of Physicians and the American College of Neuropsychopharmacology, and Distinguished Fellow of the American Society of Addiction Medicine. 

Dr. Brown is a resident of Kings County and was raised in the Van Dyke houses of Brownsville Brooklyn. He received the Bronze Star for meritorious service during US Army service in Vietnam. He has served on both New York State (Public Health and Behavioral Health) and federal advisory (NIDA, NIAID, FDA) boards.

Migdalia Jimenez, RN BSN

Appointed By: Temporary President of the Senate
Date of Appointment: August 7, 2025

Migdalia “Micky” Jimenez is the Regional Executive Director of Capital District LATINOS (CDL), and has more than 45 years of experience in healthcare and community advocacy. A Registered Professional Nurse, she began her career in addiction treatment and most recently led the Acacia Network/Camino Nuevo Chemical Dependency Treatment Program, expanding services from 40 to more than 600 clients.

Since 2018, Micky has overseen CDL’s growth, securing DOH-OMH grants to address health disparities and launching initiatives focused on addiction recovery, food insecurity, mental health, and culturally responsive services for Latino, LGBTQ+, immigrant, and other underserved communities. During the COVID-19 pandemic, she helped coordinate essential supply distribution and vaccination outreach.

A Brooklyn native of Puerto Rican heritage, Micky has served the Capital Region for nearly four decades. She holds a BS in Nursing from Long Island University, completed executive education at Babson College, and remains a dedicated advocate for equity, dignity, and community healing.

Ashley Livingston

Appointed By: Speaker of the Assembly
Date of Appointment: March 17, 2022
 

Ashley Livingston is a person in long term sustained recovery. As a founding member and current co-chair of Friends of Recovery Warren and Washington, her advocacy has been instrumental over the last decade, educating our communities about addiction and encouraging their support for recovery. 

Ashley strives to be a change-maker for individuals, communities, New York State, and extends her knowledge, voice, and advocacy to the federal level. She ensures the voices of impacted persons are heard. She is passionate about recovery, ensuring public policies protect the dignity of all people, and her family, which includes her ‘fur babies’: Roscoe, Raven, and Princess.

Cheryll Moore, BSN

Appointed By: Association of Counties
Date of Appointment: June 1, 2022

Cheryll Moore, BSN, started out in public health education before moving into senior leadership as a medical care administrator. Over her career, she became an expert in managing large-scale health assessments, securing and coordinating major grants, and leading community advocacy efforts. She holds a degree in nursing from D’Youville College and has specialized training in rural leadership and community health building.
 

Cheryll spent 25 years at the Erie County Department of Health, eventually retiring as a Medical Care Administrator. During her time there, she founded and led the Erie County Opiate Epidemic Task Force, a program that gained national recognition for its impact. Today, she works as a private consultant, helping groups like the Seneca Nation’s Opioid Department plan how to best use and distribute opioid settlement funds. In addition to her consulting work, Cheryll also serves on the Town of Amherst Opioid Court Foundation Board and the Substance Use Subcommittee of the Mental Health Community Services Board.

Driven by the personal loss of her sister in 2011, Cheryll utilizes her extensive administrative experience and clinical background to ensure no other family has to endure a similar tragedy. 

Michael Orth, M.S.W. 

Appointed By: Temporary President of the Senate (selected from a list of nominees by the Association of Counties)
Date of Appointment: June 23, 2025
 

Michael Orth has dedicated more than 37 years to public service in the human services sector. He joined the Westchester County Department of Community Mental Health (DCMH) in 1993 and was appointed Commissioner in January 2018.
 

As Commissioner, Michael oversees the planning, administration, oversight, and coordination of a comprehensive behavioral health system. The Department is responsible for mental health, substance use, and developmental/intellectual disability services, ensuring accessible, high-quality, and person-centered care for individuals and families across the lifespan.

Michael serves as Co-Chair of the Westchester County Opioid Response and Overdose Prevention Initiative (ORI) and Co-Chair of the Coordinated Children’s Services Initiative (CCSI) Planning Committee. He played a key role in developing Westchester County’s System of Care for children with emotional, social, and behavioral challenges, working in partnership with federal, state, and local agencies to build integrated, family-driven supports.

In 2020, Michael was appointed by the Governor to serve on the New York State Behavioral Health Services Advisory Council. He serves as 1st Vice Chair of the Executive Board of the New York State Conference of Local Mental Hygiene Directors (NYS CLMHDS).
 
Michael earned his Bachelor of Social Work from Iona College and his Master of Social Work from Fordham University’s Graduate School of Social Service.

Carmen G. Rivera

Appointed By: Speaker of the Assembly
Date of Appointment: March 17, 2022
 

Carmen G. Rivera serves as Senior Vice President and Chief Vocational and Community Affairs Officer at VIP Community Services. In this capacity, she provides executive oversight of vocational initiatives and community engagement strategies, with a focus on building and sustaining partnerships that enhance access to services and economic opportunity.  

Ms. Rivera has a long-standing history of governance with VIP, having served on its Board of Directors for three decades, including multiple terms as Chair. Her tenure has encompassed organizational growth, programmatic expansion, and strengthened community alignment.  

Beyond VIP, Ms. Rivera holds key leadership roles in public safety and civic engagement. She is President of the 48th Precinct Community Council, where she facilitates coordination between precinct leadership and community stakeholders. She previously served on Community Board 9, including nine years on its Executive Committee, and currently serves on Community Board 6 as Public Safety Chair. She is also a member of the Executive Committee of the Discovery for Justice Coalition, a nonprofit dedicated to advancing criminal justice reform.  

Earlier in her career, Ms. Rivera held senior positions in the publishing industry, advancing initiatives to support literacy among Spanish-speaking communities. In 2009, she was recognized with an inaugural Lifetime Achievement Distinction for her contributions to the Latino community.

Joyce A. Rivera, PhD, MPhil, MA

Appointed By: Temporary President of the Senate
Date of Appointment: February 7, 2022 (effective March 18, 2022)
 

As President of St. Ann’s Corner of Harm Reduction (SACHR), the longest-running harm reduction organization in New York City and the United States, Joyce has worked for more than thirty years advancing equitable public health, socially just drug policies, and supporting vulnerable communities. 

Her leadership has focused on reducing preventable drug-related mortality, challenging discriminatory drug laws, and mitigating the social and economic impact of punitive drug laws on New Yorkers. Key accomplishments include driving changes for pragmatic and successful drug policy changes, contributing to reductions in injection-related HIV/AIDS, leading community interventions during the HIV/AIDS and opioid epidemics, and advocating for public health-oriented policy reforms. 
 
Joyce earned her PhD, MPhil and MA in Political Science from the Graduate Center of the City University of New York. 

Dr. Angelia Smith-Wilson, EdD, MSW

Appointed By: Governor
Date of Appointment: February 18, 2026
 

Dr. Smith-Wilson has over 25 years’ experience in the Human Services and Addictions field. She has worked with human service agencies, providing services and support to those with mental health, substance use, and housing needs, and currently serves as the Executive Director of Friends of Recovery NY.

Angelia is committed to improving recovery and treatment outcomes for those in recovery, as well as enhancing the development of substance use counselors. Her dissertation, entitled, “Examining the Relationship between the Substance Abuse Counselor Knowledge of the Models of Disability and their self assessment of cultural competence working with the Deaf Sign Language User,” afforded her the opportunity to gain experience and study addictions from the counselor’s perspective. Her research led her to develop training centered around cultural humility and its application to collaborating with individuals in recovery. 

Dr. Smith-Wilson has a B.S. in Psychology from SUNY Brockport, Master of Social Work from Roberts Wesleyan College and a Doctorate in Education from St. John Fisher College. Dr. Smith-Wilson has served as an adjunct faculty at the School of Social Welfare, Graduate MSW Program.

Sandeep Varma, MS, LCSW, CASAC

Appointed By: Governor
Date of Appointment: December 1, 2025
 

Sandeep Varma joined New York Therapeutic Communities (NYTC), Inc. in 1998 as Regional Director and became Executive Vice President in 2007. Mr. Varma was appointed President/CEO in July 2018. In this capacity he supervises all clinical programs of the agency and ensures compliance with all regulations of the NYS Office of Addiction Services & Supports (OASAS). He also liaises with state agencies, legislators, and other community-based treatment providers, and works closely with the Board on overall agency planning and management. He oversees all training activities of the agency, including oversight of NYTC’s Education & Training provider certification from OASAS.
 

Mr. Varma, a Licensed Clinical Social Worker and Credentialed Alcoholism and Substance Abuse Counselor, began his career at Hospitality House in Albany, New York. He has also worked as a Psychiatric Social Worker at Bellevue-New York University Medical Center and as Senior Case Manager for Treatment Alternatives to Street Crime (TASC). He has assisted in the development of an in-prison therapeutic community training curriculum for the University of Missouri and served as consultant for the National Development and Research Institutes (NDRI). He is the past chair of the Criminal Justice Committee of the Alcohol and Substance Abuse Providers (ASAP) Association of New York State (now the InUnity Alliance).
 

He currently serves as the President of the Board of Treatment Communities of America (TCA), the Chairperson of the Therapeutic Community Association of NY (TCANY) and serves on the Board of InUnity Alliance, where he formerly served as the chair of the Criminal Justice Committee. He is also the immediate Past Chairperson of the Coalition for Community Services of New York State. Mr. Varma has a Master of Science degree from the Columbia University School of Social Work and a Certificate in Non-Profit Management from the Harvard Business School.

Kevin D. Watkins, M.D., MPH

Appointed By: Minority Leader of the Senate (selected from a list of nominees by the Association of Counties)
Date of Appointment: November 8, 2021
 

Kevin D. Watkins, M.D., MPH is a primary care physician who has served as Public Health Director for the Cattaraugus County Health Department since 2009. He brings extensive expertise in community health, population health management, and the development of strategies to address complex public health challenges, including substance use and opioid prevention. 

His leadership has focused on advancing evidence-based initiatives and improving health outcomes across diverse populations. Dr. Watkins earned both his Bachelor of Science degree and Master of Public Health degrees from the University of Illinois, and his Doctor of Medicine from Chicago Medical School. He has a strong training background in primary care medicine, which informs his approach to community health and preventive care. 

Dr. Watkins serves as Co-Chair of the Cattaraugus County Heroin/Opioid Task Force, leading coordinated efforts to address opioid use through prevention, treatment, and harm reduction. As a physician, he has treated patients with opioid use disorder, and as a Public Health Director, he has reviewed numerous opioid overdose death certificates, providing both clinical and population-level insight. He also serves on the Cattaraugus County Overdose Data Committee, supporting data-driven strategies to reduce overdose and improve outcomes. 

Taylor Ann Winter-Boberg

Appointed By: Speaker of the Assembly (selected from list of nominees by an Association of Counties)   
Date of Appointment: December 10, 2025

Taylor Ann Winter-Boberg is a public health professional with a decade of experience advancing prevention, harm reduction, and community health initiatives across Western New York. She currently serves as Community Opioid Response Director for Erie County, where she oversees the strategic allocation, contracting, and evaluation of opioid settlement funds supporting prevention, treatment, recovery, and harm reduction initiatives.

Her prior roles include leading opioid overdose response and harm reduction initiatives at the Erie County Department of Health, where she managed naloxone distribution, supervised outreach teams, and advanced data-driven strategies to reduce overdose deaths. She has also led state and federally funded public health initiatives, managed complex contracts, and convened cross-sector partnerships to improve outcomes for youth and vulnerable populations.

Taylor began her career in nonprofit leadership, directing programs focused on teen pregnancy prevention and anti-human trafficking, with an emphasis on systems coordination and trauma-informed care. She holds a Bachelor of Science in Public Health and Interdisciplinary Studies from Slippery Rock University.

Agency Leadership

Board Charter

Mission

The mission of the Opioid Settlement Fund Advisory Board is to annually review and provide recommendations on how funding received by the opioid settlement fund pursuant to Section ninety-nine-nn of the state finance law shall be spent by the legislature. The effective use of opioid settlement funding is to impact the dual goals of (1) increasing access to addiction services for individuals with or at risk of substance use disorder and (2) decreasing opioid related overdose and other negative consequences associated with substance use.

Individual Board Member Ethics

Individual board members will at all times:

  1. Disclose any real or perceived conflicts of interest that may be associated with any recommendations discussed by the Board.
  2. Operate with no preconceived funding amounts that must be allocated to any specific permissible use category.

Board Ethos

Members of the Opioid Settlement Fund Advisory Board (OSFAB) agree to act in accordance with the terms of the statute, the settlement agreements, the bylaws accepted by the board, and in the best interests of all New Yorkers with, or at risk of developing, a substance use disorder.

  1. In order to achieve the expected provisions, with the recognition that the Overdose Epidemic is indeed a public health emergency, the board agrees that all recommendations will be assessed through a public health lens taking into account population health data, social determinants of health, and health disparity data.
  2. The board recognizes that equity, or the lack thereof, is a major contributor to achieving outcomes that align with ending this epidemic. The members of the board agree that it is of the utmost importance that all processes utilized by this board are transparent, and deliberately and intentionally elevate the voices that have been systematically silenced and that recommendations from the board look to provide funding toward evidence-based services that have been typically underfunded.
  3. The Board is made up of twenty-one members, serving three-year terms, except for the governmental representatives, who hold their seats by virtue of their official positions. Board members serve three-year terms; in the event of a vacancy some members may be appointed to complete unexpired terms, and some members will remain as holdovers until a successor is appointed.

Board Scope

The board scope can be found in section 25.18(C)(1) as follows:

“Recommendations shall be evidence-based and may take into consideration federal, state or local initiatives and activities that have shown to be effective in preventing and treating substance use disorders as well as maintaining recovery and assisting with the collateral effects of substance use disorders for individuals and their families or support system. Such recommendations shall also take into account any gaps in access to services or programs identified as eligible expenditures and incorporate mechanisms for measurable outcomes for determining the effectiveness of funds expended. The office [Office of Addiction Support and Services] and any other relevant agency that provides or regulates eligible expenditures shall provide any necessary staff, resources and technical assistance to assist with the functions of the advisory board. Such assistance shall be supported pursuant to an appropriation by the legislature, in accordance with the statewide opioid settlement agreements.”

  1. The board recognizes the eligible expenditures that can be found in 25.18(a) of the Mental Hygiene Law.
  2. Given the enormity of the task at hand, the board is in agreement that it is the duty of this board, to develop both a framework for how recommendations will be presented to the board, and a rubric of estimated funding allotments for each of the allowable uses within the overlay of a public health lens as outlined above. Annually the board will reassess both the framework and the rubric and make appropriate changes to both, before hearing or assessing new recommendations.
  3. The Board recognizes that both the framework for assessing initial recommendations and the rubric outlining expenditure amounts will be indispensable in terms of meeting its annual obligation as described in section 25.18(C)10, as follows: 

    “On or before November first of each year, beginning one year after the initial deposit of monies in the opioid settlement fund, the relevant commissioners, shall provide a written report to the governor, temporary president of the senate, speaker of the assembly, chair of the senate finance committee, chair of the assembly ways and means committee, chair of the senate alcoholism and substance abuse committee, chair of the assembly alcoholism and drug abuse committee, and the opioid settlement advisory board. Such reports shall be presented as a consolidated dashboard and be made publicly available on the respective offices' websites. The report shall, to the extent practicable after making all diligent efforts to obtain such information, include the following: (i) the baseline funding for any entity that receives funding from the opioid settlement fund, prior to the receipt of such opioid settlement funds; (ii) how funds deposited in the opioid settlement fund had been utilized in the preceding calendar year, including but not limited to: (A) the amount of money disbursed from the fund and the award process used for such disbursement, if applicable; (B) the names of the recipients, the amounts awarded to such recipient and details about the purpose such funds were awarded for, including what specific services and programs the funds were used on and what populations such services or programs served;(C) the main criteria utilized to determine the award, including how the program or service assists to reduce the effects of substance use disorders; (D) an analysis of the effectiveness of the services and/or programs that received opioid settlement funding in their efforts to reduce the effects of the overdose and substance use disorder epidemic. Such analysis shall utilize evidence-based uniform metrics when reviewing the effects the service and/or program had on prevention, harm reduction, treatment, and recovery advancements; (E) any relevant information provided by the New York subdivisions pursuant to this section; and (F) any other information the commissioner deems necessary to help inform future appropriations and funding decisions, and ensure such funding is not being used to supplant local, state, or federal funding.”

Board Operating Principals

In order to deliver upon the Board’s obligations and as outlined in both sections 25.18(c)(1) and 25.18(c)(10) it is the responsibility of the Government Representatives to provide data as described but not limited to what is outlined below, and it is the duty of the board to conduct several items of business both annually and quarterly before hearing submission requests.

  1. Board Bylaw Tasks
    1. Annual analysis of the board demographics with recommendations
    2. Annual summary by the Chair of board member conflict of interest statements
    3. Annual decisions on meeting dates
  2. Annual Opioid Settlement Fund Status Updates
    1. Explanation of amounts that would have been under board purview but were disbursed or advanced.
    2. Expectation of fund growth for the next year.
  3. Annual Presentations by OMH, OASAS and DOH on:
    1. Public health data and gaps in needed services.
    2. Information about all programs that currently address each of the allowable uses.
    3. Outcome measures from each program.
    4. Gaps in funding.
    5. Current best practices, along with the data that substantiates the best practice, for each of the uses as this may not match current programming.
  4. Annual development of or amendment to the framework for the submission of recommendations for board assessment. Recommendations to be presented by the board shall at least include:
    1. Current funding source.
    2. Evidence for the program.
    3. Evidence that stakeholders have weighed in on the program.
    4. As the board recognizes it would be unethical for funds to be disbursed to any one organization, all recommendations must include evidence that the funds are to be distributed through a competitive Request For Proposal (RFP) process that is fair and accessible especially to organizations with a prioritization for unserved and underserved communities.
  5. Annual development of or amendment to the rubric of estimated funding allotments for each of the allowable uses within the overlay of a public health lens

Board members agree to:

  • Disclose any real or perceived conflicts of interest that may be associated with any recommendations discussed by the Board.
  • Operate with no preconceived funding amounts that must be allocated to any specific permissible use category.
  • Submit recommendations for consideration that are evidence-based and identify techniques for evaluation of effectiveness.
  • Make recommendations in accordance with the categories outlined above, unless the Board votes to adopt additional permissible uses in response to the changing nature of substance use in New York State.
  • Assist in the development of an annual report detailing the recommendations and evaluation of previous funding utilization.

Public Participation

The New York State Opioid Settlement Fund Advisory Board (Board) welcomes interested observers at its meetings. The meetings are open to the public in accordance with the Open Meeting Law. To make these meetings as productive as possible, however, the Board has established certain guidelines as it pertains to public participation.

Meeting Guidelines
  1. Discussion and Public Presentations
    1. Board: Discussion during the meeting of the full Board is limited to Board members and staff. Public presentations will be limited to the time allotted on the agenda
    2. Presentations:
      1. Those who wish to participate shall identify themselves to a staff person prior to the meeting and indicate the agenda item they would like to support, oppose or comment on. Advance registration for public participation, whether in-person or via videoconferencing, may be required. Such advance registration requirements will be posted on the meeting notice.
      2. Except as otherwise provided in these Guidelines or at the discretion of the Chair, there will be a limit of three minutes for oral presentations. In the interest of having the meeting progress in a timely manner, one representative of an organization or facility shall be appointed as a spokesperson for that group. Also, it is requested that all members of the public, whether an individual or a representative of a group or facility, present only new views or ideas on an agenda item, rather than reiterate a thought or position similar to a previous presenter.
      3. Handouts are not permitted.
  2. Written Materials: Written materials relevant to the agenda of the Board must be sent, preferably by electronic transmission, to the Executive Secretary at least five business days prior to the meeting: Joelle Foskett, Director of Government Affairs, OASAS, 1450 Western Ave, Albany, NY 12203. The Executive Secretary will share communications with the Board Chair, who in turn will verbally summarize the material for the Board members. If the material is not submitted in advance, but is brought to a meeting, it will not be distributed but will instead be considered for a future meeting.
  3. Press Inquiries: All Press inquiries concerning Board or Department activities should be directed to the Executive Secretary.
  4. Observers will be accommodated within the physical limitations of the meeting room and in accordance with the number allowed by the building’s fire safety code.

Annual Reports

The Board provides their recommendations in a written report to the Governor, the temporary President of the Senate, the Speaker of the Assembly, the Chair of the Senate Finance Committee, the Chair of the Assembly Ways and Means Committee, and the Chairs of the Senate and Assembly Alcoholism and Substance Abuse Committees by November 1st each year.

Annual Reports & Response Letters

2025 Report & Response Letter 2024 Report & Response Letter 2023 Report & Response Letters 2022 Report & Response Letters